SCHEMBL30730846

SCHEMBL30730846

O=C(NCc1ccncc1)c1cc2c(-c3cncc(-c4ccc(N5CCCC5=O)cc4)c3)ccnc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 1/20 0.44
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 1/20 0.42
METTL3 Q86U44 1/20 0.42
METTL14 Q9HCE5 1/20 0.42
NUDT1 P36639 2/20 0.42
GALR3 O60755 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
TBK1 Q9UHD2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
NAMPT P43490 2/20 0.40
KLKB1 P03952 2/20 0.40
KLK1 P06870 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22554047 1.00 DGAT2 (0.44) DGAT2LMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL22554129 0.94 METTL3 (0.46) DGAT2LMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL22554033 0.92 NPC1 (0.43) DGAT2LMNANUDT1TBK1ALDH1A1
SCHEMBL30730856 0.92 NUDT1 (0.47) DGAT2LMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL30777577 0.92 NPC1 (0.43) DGAT2LMNANUDT1TBK1ALDH1A1
SCHEMBL22554104 0.92 NUDT1 (0.47) DGAT2LMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL30730866 0.88 DGAT2 (0.43) DGAT2LMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL22553765 0.88 DGAT2 (0.41) DGAT2LMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL22554015 0.88 DGAT2 (0.43) DGAT2LMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL22553904 0.88 NPC1 (0.49) DGAT2SMN1; SMN2L3MBTL1MAPTNUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112088157-B Aryl-bipyridylamine derivatives as phosphatidylinositol phosphokinase inhibitors 拉文纳制药公司 2023-12-26 CN claimed
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
CN-112088157-B Aryl-bipyridylamine derivatives as phosphatidylinositol phosphokinase inhibitors 拉文纳制药公司 2023-12-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C DGAT2 4196/4885LMNA 3441/4885SMN1; SMN2 3679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.